LIVE ATTENUATED ROTAVIRUS VACCINE FOR ORAL ADMINISTRATION

• 1. 口服施用的活减毒轮状病毒疫苗 [P] . 中国专利： CN101300028B . 2014.06.04
• 2. 口服施用的活减毒轮状病毒疫苗 [P] . 中国专利： CN103357005A . 2013-10-23
• 3. Live attenuated rotavirus vaccine for oral administration [P] . 美国专利： US8821891B2 . 2014-09-02

  机译： 口服减毒轮状病毒活疫苗

• 4. LIVE ATTENUATED ROTAVIRUS VACCINE FOR ORAL ADMINISTRATION [P] . 韩国专利： KR101319846B1 . 2013-10-22

  机译： 口服口服减毒轮状疫苗

• 5. Live attenuated rotavirus vaccine for oral administration [P] . AP2692A . 2013-07-16

  机译： 口服减毒轮状病毒活疫苗

• 1. Recent advances in particulate drug delivery systems: Oral, pulmonary, and ophthalmic administrations [J] . Hirofumi Takeuchi, Kohei Tahara, Risako Onodera 亚洲药物制剂科学(英文) . 2016,第001期
• 2. Oral Immunization of Mice With Vaccine of Attenuated Salmonella typhimurium Expressing Helicobacter pylori Urease B Subunit [J] . XING-LONG YANG, WEN-CHAO LIU, WU-WEI YANG, 生物医学与环境科学（英文版） . 2005,第006期
• 3. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines [J] . Steele A. D., De Vos B., Tumbo J., Vaccine . 2010,第39期
• 4. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC (R) in comparison with a licensed rotavirus vaccine in healthy infants [J] . Vaccine . 2019,第31期
• 5. Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine rix4414 coadministered with oral polio vaccine in south african infants [J] . SteeleA.D., ReyndersJ., ScholtzF., The Journal of Infectious Diseases . 2010,第Suppla1期
• 6. FORMULATION DEVELOPMENT OF A STABLE, ORALLY DELIVERED LIVE HUMAN NEONATAL ROTAVIRUS (RV3-BB) VACCINE CANDIDATE [C] . Prashant Kumar, Swathi Pullagurla, Ravi S. Shukla, Conference on vaccine technology VI . 2018
• 7. Simulating the impacts of mass vaccination with live attenuated human rotavirus vaccine in a developing country. [D] . Rose, Johnie. 2010
• 8. Overview of the Development Impacts and Challenges of Live-Attenuated Oral Rotavirus Vaccines [O] . Olufemi Samuel Folorunso, Olihile M. Sebolai 2020
• 9. Oral live attenuated human rotavirus vaccine (Rotarix^TM) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children [O] . JUSTINO, Maria Cleonice Aguiar, ARAÚJO, Eliete da Cunha, VAN DOORN, Leen-Jan, 2012
• 10. Clinical and Laboratory Observations Following Oral or IntramuscularAdministration of a Live Attenuated Hepatitis A Vaccine Candidate [R] . Sjogren, M. H., Purcell, R. H., McKee, K., 1992

• 1. Oral Administration Following Subcutaneous Administration of FCV Vaccines Enhances Vaccine Efficacy against Challenge of a Highly Virulent Vs Feline Calicivirus [J] . Sing Rong ,Kim Floyd-Hawkins ,Vicki King . 疫苗（英文） . 2014,第2期
• 2. Oral attenuated Salmonella typhimurium vaccine against MG7-Ag mimotope of gastric cancer [J] . Fan-PingMeng JieDing Zhao-CaiYu Quan-LiHan Chang-CunGuo NaLiu Dai-MingFan . 世界胃肠病学杂志：英文版 . 2005,第12期
• 3. Development of an oral DNA vaccine against MG7-Ag of gastric cancer using attenuated salmonella typhimurium as carrier [J] . Quan-LiHan ,Fan-PingMeng ,NaLiu . 世界胃肠病学杂志：英文版 . 2003,第6期
• 4. 口服轮状病毒活疫苗接种无菌兔的免疫原性研究 [C] . 李东 ,国泰 ,刘悦越 . 第十次全国生物制品学术会议 . 2009
• 5. 减毒鼠伤寒沙门氏菌介导的抗原递呈系统在肿瘤治疗性口服DNA疫苗及蛋白质疫苗制备中的应用 [A] . 朱向莹 . 2010